Salmen, Anke

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2019 | 2018 | 2017 | 2016

2019

Kamm, Christian Philipp; Barin, L; Gobbi, C; Pot, C.; Calabrese, P; Salmen, Anke; Achtnichts, L; Kesselring, J; Puhan, M A; von Wyl, V. (2019). Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study. (In Press). Journal of neurology Springer-Medizin-Verlag 10.1007/s00415-019-09563-y

Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8

Gasperi, Christiane; Salmen, Anke; Antony, Gisela; Bayas, Antonios; Heesen, Christoph; Kümpfel, Tania; Linker, Ralf A; Paul, Friedemann; Stangel, Martin; Tackenberg, Björn; Bergh, Florian Then; Warnke, Clemens; Weber, Frank; Wiendl, Heinz; Wildemann, Brigitte; Zettl, Uwe K; Ziemann, Ulf; Zipp, Frauke; Tumani, Hayrettin; Gold, Ralf; ... (2019). Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA neurology, 76(7), pp. 841-849. American Medical Association 10.1001/jamaneurol.2019.0905

Graetz, Christiane; Gröger, Adriane; Luessi, Felix; Salmen, Anke; Zöller, Daniela; Schultz, Janine; Siller, Nelly; Fleischer, Vinzenz; Bellenberg, Barbara; Berthele, Achim; Biberacher, Viola; Havla, Joachim; Hecker, Michael; Hohlfeld, Reinhard; Infante-Duarte, Carmen; Kirschke, Jan S; Kümpfel, Tania; Linker, Ralf; Paul, Friedemann; Pfeuffer, Steffen; ... (2019). Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Multiple sclerosis journal, 25(5), pp. 661-668. Sage 10.1177/1352458518763541

Miclea, A.; Salmen, Anke; Zoehner, G.; Diem, Lara; Kamm, Christian P.; Chaloulos-Iakovidis, Panagiotis; Miclea, M.; Briner, Myriam Sandra; Kilidireas, K.; Stefanis, L.; Chan, Andrew; Evangelopoulos, Maria Eleptheria; Hoepner, Robert (2019). Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. CNS neuroscience & therapeutics, 25(4), pp. 527-531. Blackwell Publishing 10.1111/cns.13083

Johnen, A.; Burkner, P. C.; Landmeyer, N. C.; Ambrosius, B.; Calabrese, P.; Motte, J.; Hessler, N.; Antony, G.; Konig, I. R.; Klotz, L.; Hoshi, M. M.; Aly, L.; Groppa, S.; Luessi, F.; Paul, F.; Tackenberg, B.; Bergh, F. T.; Kumpfel, T.; Tumani, H.; Stangel, M.; ... (2019). Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). Journal of neurology, 266(2), pp. 386-397. Springer-Medizin-Verlag 10.1007/s00415-018-9142-y

Barin, Laura; Kamm, Christian P.; Salmen, Anke; Dressel, Holger; Calabrese, Pasquale; Pot, Caroline; Schippling, Sven; Gobbi, Claudio; Müller, Stefanie; Chan, Andrew; Rodgers, Stephanie; Kaufmann, Marco; Ajdacic-Gross, Vladeta; Steinemann, Nina; Kesselring, Jürg; Puhan, Milo A; von Wyl, Viktor (2019). How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis (In Press). Multiple sclerosis journal, p. 1352458518823955. Sage 10.1177/1352458518823955

Barin, L.; Kaufmann, M.; Salmen, Anke; Kamm, Christian P.; Gobbi, C.; Kuhle, J.; Pot, C.; Chan, Andrew; Czaplinski, A.; Ajdacic-Gross, V.; Rodgers, S.; Kesselring, J.; Puhan, M. A.; von Wyl, V. (2019). Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study. Multiple Sclerosis and Related Disorders, 28, pp. 17-25. Elsevier 10.1016/j.msard.2018.11.033

Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652

Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450

Achtnichts, Lutz; Chan, Andrew; Czaplinski, Adam; Derfuss, Tobias; Du Pasquier, Renaud; Findling, Oliver; Gobbi, Claudio; Hoepner, Robert; Kamber, Nicole; Kamm, Christian P.; Kuhle, Jens; Lalive, Patrice; Lutterotti, Andreas; Martin, Roland; Mller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Salmen, Anke; Schippling, Sven and Zecca, Chiara (2019). Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz. Swiss Medical Forum, 19(41-42), pp. 676-685. EMH Swiss Medical Publishers 10.4414/smf.2019.08356

Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340

Skorupka, Nic; Miclea, Andrei; Jalowiec, Katarzyna Aleksandra; Bocksrucker, Christoph; Kamber, Nicole; Chan, Andrew; Mansouri Taleghani, Behrouz; Hoepner, Robert; Salmen, Anke (2019). Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfusion medicine and hemotherapy, 46(6), pp. 417-422. Karger 10.1159/000504027

2018

Kaufmann, M.; Kuhle, J.; Puhan, M. A.; Kamm, Christian Philipp; Chan, Andrew; Salmen, Anke; Kesselring, J.; Calabrese, P.; Gobbi, C.; Pot, C.; Steinemann, N.; Rodgers, S.; von Wyl, V. (2018). Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland. Multiple sclerosis journal - experimental, translational and clinical, 4(4), p. 2055217318814562. Sage Publications 10.1177/2055217318814562

Salmen, Anke (2018). Clinical commentary on "Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab". Multiple sclerosis journal, 24(3), pp. 360-362. Sage 10.1177/1352458517717810

Rummel, Christian; Aschwanden, Fabian; McKinley, Richard; Wagner, Franca; Salmen, Anke; Chan, Andrew; Wiest, Roland (2018). A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease. Frontiers in neurology, 8, p. 727. Frontiers Media S.A. 10.3389/fneur.2017.00727

Thiel, S.; Leypoldt, F.; Röpke, L.; Wandinger, K.; Kümpfel, T.; Aktas, O.; von Bismarck, O.; Salmen, Anke; Ambrosius, B.; Ellrichmann, G.; Antony, G.; Dankowski, T.; Ziegler, A.; Stahmann, A.; Meyer, C.; Eichstädt, K.; Buckow, K.; Meißner, T.; Thibaut, J.; Khil, L.; ... (2018). Neuroimmunological Registries in Germany. Neurology international open, 02(01), E25-E39. Thieme 10.1055/s-0043-108830

von Bismarck, Olga; Dankowski, Theresa; Ambrosius, Björn; Hessler, Nicole; Antony, Gisela; Ziegler, Andreas; Hoshi, Muna-Miriam; Aly, Lilian; Luessi, Felix; Groppa, Sergiu; Klotz, Luisa; Meuth, Sven G.; Tackenberg, Björn; Stoppe, Muriel; Then Bergh, Florian; Tumani, Hayrettin; Kümpfel, Tania; Stangel, Martin; Heesen, Christoph; Wildemann, Brigitte; ... (2018). Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurology: Neuroimmunology and Neuroinflammation, 5(3), e446. Wolters Kluwer Health 10.1212/NXI.0000000000000446

Barin, Laura; Salmen, Anke; Disanto, Giulio; Babačić, Haris; Calabrese, Pasquale; Chan, Andrew; Kamm, Christian P.; Kesselring, Jürg; Kuhle, Jens; Gobbi, Claudio; Pot, Caroline; Puhan, Milo A.; von Wyl, Viktor (2018). The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Multiple Sclerosis and Related Disorders, 25, pp. 112-121. Elsevier 10.1016/j.msard.2018.07.013

Wagner, Franca; Grunder, Lorenz Nicolas; Hakim, Arsany; Kamber, Nicole; Horn, Michael; Müllner, Julia Nicole Maria; Hoepner, Robert; Wiest, Roland; Metz, Imke; Chan, Andrew; Salmen, Anke (2018). Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in neurology, 9(782), p. 782. Frontiers Media S.A. 10.3389/fneur.2018.00782

2017

Hagström, Inga T; Schneider, Ruth; Bellenberg, Barbara; Salmen, Anke; Weiler, Florian; Köster, Odo; Gold, Ralf; Lukas, Carsten (2017). Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study. Journal of neurology, 264(7), pp. 1402-1412. Springer-Medizin-Verlag 10.1007/s00415-017-8537-5

Salmen, Anke; Chan, Andrew (2017). NMO-Spektrum-Erkrankungen (NMOSE). In: Berlit, P (ed.) Klinische Neurologie. Springer Reference Medizin (pp. 1-15). Berlin; Heidelberg: Springer 10.1007/978-3-662-44768-0_161-1

2016

Kinner, Markus; Hoepner, Robert; Klotz, Peter; Prehn, Christian; Faissner, Simon; Salmen, Anke; Linker, Ralf A; Gold, Ralf; Chan, Andrew (2016). Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis. CNS neuroscience & therapeutics, 22(12), pp. 1019-1022. Wiley 10.1111/cns.12652

Hoepner, Robert; Kolb, Eva M; Dahlhaus, Stefanie; Hellwig, Kerstin; Adams, Ortwin; Kleiter, Ingo; Salmen, Anke; Schneider, Ruth; Lukas, Carsten; Chan, Andrew; Berger, Joseph R; Gold, Ralf (2016). Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple sclerosis journal, 23(6), pp. 830-835. Sage 10.1177/1352458516667241

Recke, A; Oei, A; Hübner, F; Fechner, K; Graf, J; Hagenah, J; May, C; Woitalla, D; Salmen, Anke; Zillikens, D; Gold, R; Schlumberger, W; Schmidt, E (2016). Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction. British journal of dermatology, 175(2), pp. 407-409. Wiley-Blackwell 10.1111/bjd.14538

Andlauer, Till F M; Buck, Dorothea; Antony, Gisela; Bayas, Antonios; Bechmann, Lukas; Berthele, Achim; Chan, Andrew; Gasperi, Christiane; Gold, Ralf; Graetz, Christiane; Haas, Jürgen; Hecker, Michael; Infante-Duarte, Carmen; Knop, Matthias; Kümpfel, Tania; Limmroth, Volker; Linker, Ralf A; Loleit, Verena; Luessi, Felix; Meuth, Sven G; ... (2016). Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science Advances, 2(6), e1501678. American Association for the Advancement of Science 10.1126/sciadv.1501678

Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1

Salmen, Anke; von Ahsen, N.; Trampe, A. K.; Hoepner, R.; Plavina, T.; Subramanyam, M.; Kuesters, G.; Gold, R.; Chan, Andrew (2016). Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy. Multiple sclerosis journal - experimental, translational and clinical, 2, p. 205521731663000. Sage Publications 10.1177/2055217316630008

Salmen, Anke; Linker, R; Gold, R (2016). "Oral Dimethyl Fumarate (BG-12; Tecfidera®) for Multiple Sclerosis.". In: Arnon, Ruth; Miller, Ariel (eds.) Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications. (pp. 271-283). Elsevier 10.1016/B978-0-12-801914-6.00022-2

Provide Feedback